angiotensin ii has been researched along with alamandine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Alenina, N; Alves, F; Alzamora, A; Bader, M; Barbosa, C; Braga, J; Campagnole-Santos, MJ; Costa-Fraga, F; Ferreira, A; Fraga-Silva, RA; Jankowski, J; Jankowski, V; Kemplin, F; Kjeldsen, F; Klempin, F; Lautner, RQ; Maia, G; Martins, A; Motta-Santos, D; Oliveira, A; Passos-Silva, D; Paula, R; Peluso, AB; Pimenta, A; Raizada, M; Santos, RA; Savergnini, S; Silva, N; Sinisterra, R; Soares, E; Sousa, F; Verano-Braga, T; Villela, DC | 1 |
| Etelvino, GM; Peluso, AA; Santos, RA | 1 |
| Azocar, A; Castro, PF; Chiong, M; Jalil, JE; Lavandero, S; Mendoza-Torres, E; Mondaca-Ruff, D; Ocaranza, MP; Oyarzún, A | 1 |
| Awan, FR; Hussain, M | 1 |
| Alves, F; Bader, M; Guatimosim, S; Jesus, ICG; Marques, K; Rocha-Resende, C; Santos, RAS; Scalzo, S | 1 |
| Agelis, G; Androutsou, ME; Antonopoulos, M; Apostolopoulos, V; Matsoukas, J; Michalatou, M; Mikkelsen, K; Qaradakhi, T; Vlahakos, DV; Zulli, A | 1 |
| Chen, X; Li, P; Liu, C; Wang, L | 1 |
| Li, Q; Prasad, T; Verma, A; Zhu, P | 1 |
| Kong, X; Li, P; Liu, C; Shen, Y; Wu, X; Yang, C | 1 |
| Jha, S; Macheroux, P; Speth, RC | 1 |
| Javanmardi, K; Soltani Hekmat, A | 1 |
| Carvalho, FB; Fernandes, RS; Netto, MRT; Rigatto, K | 1 |
| Acet, HA; Ateş, B; Özhan, O; Parlakpinar, H; Tanrıverdi, LH; Ulu, A; Vardı, N; Yıldız, A | 1 |
5 review(s) available for angiotensin ii and alamandine
| Article | Year |
|---|---|
New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.
Topics: Angiotensin I; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Oligopeptides; Peptide Fragments; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity | 2014 |
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Renin-Angiotensin System | 2015 |
Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensinogen; Angiotensins; Animals; Blood Pressure; Humans; Hypertension; Oligopeptides; Peptide Fragments; Protective Factors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction; Vasoconstriction | 2018 |
Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Oligopeptides; Peptide Fragments; Renin-Angiotensin System | 2021 |
Alamandine: A promising treatment for fibrosis.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen; COVID-19 Drug Treatment; Fibrosis; Humans; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Rats; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Vasodilator Agents | 2022 |
8 other study(ies) available for angiotensin ii and alamandine
| Article | Year |
|---|---|
Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Humans; Male; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Inbred F344; Rats, Inbred SHR; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2013 |
Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Enzyme Activation; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nerve Tissue Proteins; Nitric Oxide; Oligopeptides; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels.
Topics: Administration, Cutaneous; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Blood Vessels; Humans; Kidney; Losartan; Male; Oligopeptides; Rabbits; Rats, Wistar; Receptor, Angiotensin, Type 1; Reproducibility of Results; Skin Absorption; Valsartan; Vasodilation | 2018 |
Alamandine attenuates long‑term hypertension‑induced cardiac fibrosis independent of blood pressure.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Collagen Type I; Collagen Type I, alpha 1 Chain; Fibrosis; Heart Ventricles; Hypertension; Imidazoles; Male; Matrix Metalloproteinase 9; Oligopeptides; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 2019 |
Expression and Function of Mas-Related G Protein-Coupled Receptor D and Its Ligand Alamandine in Retina.
Topics: Aging; Angiotensin II; Animals; Cells, Cultured; Electroretinography; Humans; Ligands; Lipopolysaccharides; Mice, Inbred C57BL; Mice, Knockout; Oligopeptides; Rats; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Retina | 2020 |
Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterial Pressure; Cells, Cultured; Disease Models, Animal; Fibrosis; Hypertension; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nerve Tissue Proteins; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Vascular Remodeling | 2020 |
The possible role of a bacterial aspartate β-decarboxylase in the biosynthesis of alamandine.
Topics: Angiotensin I; Angiotensin II; Animals; Carboxy-Lyases; Humans; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, G-Protein-Coupled; Renin-Angiotensin System | 2020 |
Activation of the Mas receptors by AVE0991 and MrgD receptor using alamandine to limit the deleterious effects of Ang II-induced hypertension.
Topics: Angiotensin II; Animals; Hypertension; Matrix Metalloproteinase 2; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled | 2023 |